Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal bupivacaine + morphine for recovery after lung surgery
ChiCTR2400092935Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Yangzhou University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine and morphine in pulmonary diseases (2 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoint: Quality of recovery 1 day after surgery. Started Aug 2024; status: recruiting.
02
Drugs
bupivacainemorphine
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400092935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092935.